1 – 100 of 161
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Predictors of short-term anxiety outcome in subthalamic stimulation for Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Factors associated with self-rated health in people with late-stage parkinson’s and cognitive impairment
2024) In Quality of Life Research(
- Contribution to journal › Article
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
2024) In Movement Disorders Clinical Practice(
- Contribution to journal › Article
-
Mark
Care of Late-Stage Parkinsonism : Resource Utilization of the Disease in Five European Countries
(
- Contribution to journal › Article
-
Mark
The Care Needs of Patients With Cognitive Impairment in Late-Stage Parkinson’s Disease
2024) In Journal of Geriatric Psychiatry and Neurology(
- Contribution to journal › Article
-
Mark
A systematic practice review : Providing palliative care for people with Parkinson’s disease and their caregivers
(
- Contribution to journal › Scientific review
-
Mark
Meaning in Life in Late-Stage Parkinson’s Disease : Results from the Care of Late-Stage Parkinsonism Study (CLaSP) in Six European Countries
(
- Contribution to journal › Article
-
Mark
Economic Burden of Parkinson’s Disease : A Multinational, Real-World, Cost-of-Illness Study
2024) In Drugs - Real World Outcomes(
- Contribution to journal › Article
-
Mark
Non-Motor Symptom Management : Insights into Adherence to Treatment Guidelines in Parkinson’s Disease Patients
(
- Contribution to journal › Article
- 2023
-
Mark
Agreement Between Parkinson Disease Home Diary and Observer Assessments Before and After Structured Patient Training
2023) 2023 International Congress of The Parkinson and Movement Disorder Society(
- Contribution to conference › Abstract
-
Mark
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease
2023) In European Journal of Neurology(
- Contribution to journal › Article
-
Mark
A Paradigm Shift in the Management of Patients with Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Application of single wrist-wearable accelerometry for objective motor diary assessment in fluctuating Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum : Revelations from the MANAGE-PD validation cohort
(
- Contribution to journal › Article
-
Mark
Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment
(
- Contribution to journal › Scientific review
-
Mark
The Impact of COVID-19 on Parkinson's Disease : A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
(
- Contribution to journal › Article
-
Mark
Levodopa Dose Equivalency in Parkinson's Disease : Updated Systematic Review and Proposals
(
- Contribution to journal › Article
-
Mark
Comparison of dyskinesia profiles after L-DOPA dose challenges with or without dopamine agonist coadministration
(
- Contribution to journal › Article
-
Mark
Time to workforce exit after a Parkinson's disease diagnosis
(
- Contribution to journal › Article
-
Mark
Clinical Impression of Severity Index for Parkinson's Disease and Its Association to Health-Related Quality of Life
(
- Contribution to journal › Article
-
Mark
Agreement between Parkinson Disease Home Diary and Observer Assessments before and after Structured Patient Training
(
- Contribution to journal › Article
-
Mark
The Relationship between PDQ-8 and Costs in Parkinson's Disease—A Swedish Register-Based Study
(
- Contribution to journal › Article
-
Mark
Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson’s disease : clinical and therapeutic considerations
(
- Contribution to journal › Scientific review
-
Mark
Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson's Disease
(
- Contribution to journal › Article
- 2022
-
Mark
Caregiver Burden in Late-Stage Parkinsonism and Its Associations
(
- Contribution to journal › Article
-
Mark
Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Safinamide in the treatment pathway of Parkinson’s Disease : a European Delphi Consensus
(
- Contribution to journal › Article
-
Mark
Insights on Genetic and Environmental Factors in Parkinson's Disease from a Regional Swedish Case-Control Cohort
(
- Contribution to journal › Article
-
Mark
Validation of the PD home diary for assessment of motor fluctuations in advanced Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Opicapone versus placebo in the treatment of Parkinson’s disease patients with end-of-dose motor fluctuation-associated pain : rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial
(
- Contribution to journal › Article
-
Mark
Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Caregiver Burden and Quality of Life in Late Stage Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Diagnostic work up : Laboratory and biomarkers
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
(
- Contribution to journal › Article
-
Mark
Gait and balance among people with de novo vs. mild to moderate Parkinson’s disease
2022) 6th International Conference on Neurology and Brain Disorders (Virtual)(
- Contribution to conference › Abstract
-
Mark
Objective Observer vs. Patient Motor State Assessments Using the PD Home Diary in Advanced Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
High risk of developing dementia in Parkinson’s disease : a Swedish registry-based study
(
- Contribution to journal › Article
-
Mark
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
(
- Contribution to journal › Scientific review
-
Mark
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep : Results from a Meta-Analysis with 24-Month Follow-Up
(
- Contribution to journal › Scientific review
-
Mark
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease : A Systematic Review and Bayesian Network Meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
(
- Contribution to journal › Article
-
Mark
Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study
(
- Contribution to journal › Article
-
Mark
Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson’s Disease : Real-World Evidence From G7 Countries
(
- Contribution to journal › Article
- 2021
-
Mark
Characteristics of Patients with Late-Stage Parkinsonism who are Nursing Home Residents Compared with those Living at Home
(
- Contribution to journal › Article
-
Mark
The Non-Motor Symptoms Scale in Parkinson’s disease : Validation and use
(
- Contribution to journal › Scientific review
-
Mark
Longitudinal prediction of falls and near falls frequencies in Parkinson's disease:a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Validation and clinical value of the MANAGE-PD tool : A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications
(
- Contribution to journal › Article
-
Mark
Clinical Usefulness of Retropulsion Tests in Persons with Mild to Moderate Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson’s Disease : A Swedish Register-Based Study in 1823 Observations
(
- Contribution to journal › Article
-
Mark
Factors Associated with Health-Related Quality of Life in Late-Stage Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Perspectives on Care for Late-Stage Parkinson's Disease
(
- Contribution to journal › Scientific review
-
Mark
Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease : A Structured Review
(
- Contribution to journal › Scientific review
-
Mark
Close relationships in Parkinson´s disease patients with device-aided therapy
(
- Contribution to journal › Article
-
Mark
Parkinson’s disease in Sweden—resource use and costs by severity
(
- Contribution to journal › Article
-
Mark
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Parkinson's Disease and Post–COVID-19 Syndrome : The Parkinson's Long-COVID Spectrum
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Advance Care Planning and Care Coordination for People With Parkinson's Disease and Their Family Caregivers—Study Protocol for a Multicentre, Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Personalised advanced therapies in parkinson’s disease : The role of non-motor symptoms profile
(
- Contribution to journal › Article
-
Mark
Swedish guidelines for device-aided therapies in Parkinson's disease —Economic evaluation and implementation
(
- Contribution to journal › Article
-
Mark
Digital health technology for non-motor symptoms in people with Parkinson's disease : Futile or future?
(
- Contribution to journal › Scientific review
-
Mark
Effects of safinamide on pain in patients with fluctuating Parkinson's disease
(
- Contribution to journal › Article
- 2020
-
Mark
Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) zur Erhebung nichtmotorischer Symptome bei Dystonie : Interkulturelle Adaptation in deutscher Sprache
(
- Contribution to journal › Article
-
Mark
Parkinsons sjukdom – heterogen och komplex i sitt kliniska uttryck - Individuella kombinationer av symtom som ändrar sig över tid kräver behandlingsjusteringar och anpassningar
(
- Contribution to journal › Article
-
Mark
Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia
(
- Contribution to journal › Article
-
Mark
The late stage of Parkinson's –results of a large multinational study on motor and non-motor complications
(
- Contribution to journal › Article
-
Mark
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson’s disease patients : an European multicentre survey
(
- Contribution to journal › Article
-
Mark
Optimizing Treatment in Undertreated Late-Stage Parkinsonism : A Pragmatic Randomized Trial
(
- Contribution to journal › Article
-
Mark
Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis : The COVID-19 Experience
(
- Contribution to journal › Scientific review
-
Mark
The Prevalence and Determinants of Neuropsychiatric Symptoms in Late-Stage Parkinsonism
(
- Contribution to journal › Article
-
Mark
Levodopa infusion in Parkinson's disease : Individual quality of life
(
- Contribution to journal › Article
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
(
- Contribution to journal › Article
- 2019
-
Mark
EuroInf 2 : Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease
2019) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Low prevalence of known pathogenic mutations in dominant PD genes : A Swedish multicenter study
(
- Contribution to journal › Article
-
Mark
Satisfaction with care in late stage Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Disease stage dependency of motor and non-motor fluctuations in Parkinson's disease
(
- Contribution to journal › Article
- 2018
-
Mark
King’s Parkinson’s Disease Pain Scale : Interkulturelle Adaption in deutscher Sprache
(
- Contribution to journal › Article
-
Mark
Mobility device use in people with Parkinson's disease : A 3-year follow-up study
(
- Contribution to journal › Article
-
Mark
Reduced workforce participation 5 years prior to first Parkinson’s disease sick-leave
(
- Contribution to journal › Article
-
Mark
Dopaminergic effect on non-motor symptoms in late stage Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Continuous drug delivery aiming continuous dopaminergic stimulation in Parkinson's disease
(
- Contribution to journal › Scientific review
-
Mark
Study protocol: Care of Late-Stage Parkinsonism (CLaSP): a longitudinal cohort study
(
- Contribution to journal › Article
-
Mark
First comprehensive tool for screening pain in Parkinson's disease : the King's Parkinson's Disease Pain Questionnaire
(
- Contribution to journal › Article
-
Mark
Workforce participation and activities in Parkinson's disease patients receiving device-aided therapy
(
- Contribution to journal › Article
-
Mark
Levodopa effect and motor function in late stage Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease : a multi-country Delphi-panel approach
(
- Contribution to journal › Article
-
Mark
Systematic evaluation of levodopa-carbidopa intestinal gel patient-responder characteristics
(
- Contribution to journal › Article
-
Mark
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Device-Aided Treatment Strategies in Advanced Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Factors Contributing to Perceived Walking Difficulties in People with Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Factors associated with life satisfaction in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Algorithms for the treatment of motor problems in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Factors associated with perceived walking difficulties in people with Parkinson’s disease
2017) 21st International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Levodopa effect and motor function in late stage Parkinson’s disease
(
- Contribution to conference › Abstract
-
Mark
The Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale for use in Sweden
2017) 21st International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Workforce unavailability in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Levodopa-carbidopa intestinal gel in advanced Parkinson's : Final results of the GLORIA registry
(
- Contribution to journal › Article
-
Mark
Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?
(
- Contribution to journal › Scientific review
-
Mark
A Consensus Set of Outcomes for Parkinson's Disease from the International Consortium for Health Outcomes Measurement
(
- Contribution to journal › Article